We are live on ! Find out more
CLYM

Climb Bio
CLYM

80 hedge funds and large institutions have $221M invested in Climb Bio in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

40% more capital invested

Capital invested by funds: $157M → $221M (+$63.7M)

23% more funds holding

Funds holding: 65 → 80 (+15)

21.8% more ownership

Funds ownership: 45.79% → 67.6% (+22%)

9% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 23

Holders
80
Holders Change
+15
Holders Change %
+23.08%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
25
Reduced
23
Closed
10
Calls
$669K
Puts
–
Net Calls
+$669K
Net Calls Change
+$669K

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$8.82M
2
Millennium Management
Millennium Management
New York
+$5.65M
3
SCM
Silverarc Capital Management
Massachusetts
+$3.95M
4
Marshall Wace
Marshall Wace
United Kingdom
+$2.71M
5
GPP
Great Point Partners
Connecticut
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
-$4.82M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.79M
3
AAA
Affinity Asset Advisors
New York
-$3.46M
4
SFM
Sphera Funds Management
Israel
-$2.96M
5
PLC
Peapod Lane Capital
New York
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
76
JP Morgan Chase
New York
$301 – – –
Carson Wealth (CWM LLC)
77
Carson Wealth (CWM LLC)
Nebraska
$123 -$63 -11 -38%
AAP
78
Arax Advisory Partners
Colorado
$110 +$294 +51 New
Deutsche Bank
79
Deutsche Bank
Germany
$7 – – –
Ameriprise
80
Ameriprise
Minnesota
– -$558K -139,529 Closed
Two Sigma Advisers
81
Two Sigma Advisers
New York
– -$499K -124,700 Closed
SCM
82
Squadron Capital Management
Illinois
– -$400K -100,000 Closed
CFG
83
Citizens Financial Group
Rhode Island
– -$113K -28,168 Closed
HSBC Holdings
84
HSBC Holdings
United Kingdom
– -$99.2K -24,744 Closed
PCM
85
Prelude Capital Management
New York
– -$79.7K -19,918 Closed
CPIG
86
Chicago Partners Investment Group
Illinois
– -$55K -10,962 Closed
VF
87
Virtu Financial
New York
– -$43K -10,655 Closed
SRL
88
Scientech Research LLC
New Jersey
– -$41.7K -10,428 Closed
HI
89
Harbour Investments
Wisconsin
– -$8K -2,000 Closed
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
– -$1.9K -329 -81%
1 2 3
4

CLYM Hedge Fund Activity: Q1 2026 in Review

80 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q1 2026, worth a combined $221M — up 40% from $157M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CLYM positions and 10 closed out — a net gain of 17 holders — while 25 added to existing stakes and 23 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $8.82M. The largest seller was ADAR1 Capital Management, cutting an estimated $4.82M.

  • 80 institutional investors held Climb Bio (CLYM) as of Q1 2026, up from 65 in Q4 2025.
  • Funds reported $221M of Climb Bio stock for Q1 2026, up 40% quarter-over-quarter.
  • 27 funds opened new Climb Bio positions in Q1 2026 and 10 closed out, a net change of +17 holders.
  • The largest Climb Bio buyer in Q1 2026 was Braidwell, an estimated $8.82M added.
  • The largest Climb Bio seller in Q1 2026 was ADAR1 Capital Management, an estimated $4.82M sold.

Based on aggregated 13F filings for Q1 2026.